ONC

Beone Medicines
$341.80
−$9.20 (−2.62%)Sep 10, 2026
8.8GreatMoatMint rating

MoatMint rates Beone Medicines (ONC) 8.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 6.5 out of 10.

Key metrics

The numbers that frame ONC today
Market cap
$38.90B
P/E (TTM)
59.3
EV / FCF
26.6
Gross margin
88.9%
EV / Sales
5.8
ROIC
27.4%
Div yield
0%
Debt / equity
0.4
52wk Low
$253.95
52wk High
$385.22

ONC stock rating

How ONC scores on quality, value, growth, momentum and financial health
8.8out of 10
Great overallStrong business, fair price
Quality6.5
Growth9.2
Momentum6.8
Value6.1
Financial Health9.5

Growth

Revenue and earnings trend for ONC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ONC
Is Beone Medicines a good buy?
Yes. Beone Medicines has strong quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Beone Medicines is selling at a fair price.
What is the market capitalization of ONC?
Beone Medicines's market capitalization is $38.90B.
What is the P/E ratio for ONC stock?
Beone Medicines's current P/E ratio is 59.3.
What is the 52-week high for ONC stock?
The 52-week high for Beone Medicines is $385.22. The current close of $341.80 is 11.3% below that high.
What is the 52-week low for ONC stock?
The 52-week low for Beone Medicines is $253.95. The current close of $341.80 is 34.6% above that low.
Does ONC stock pay dividends?
Beone Medicines does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ONC?
Beone Medicines's Debt / Equity ratio is 0.4.